過去20年來，機(jī)器人技術(shù)已經(jīng)被運(yùn)用在某些特定醫(yī)療照護(hù)領(lǐng)域，以提升外科手術(shù)或是病患復(fù)健程序的效率與安全性；近幾年來，隨著機(jī)器人技術(shù)的演進(jìn)，再加上醫(yī)療照護(hù)市場景氣蓬勃，也讓各種手術(shù)用、輔助用以及遠(yuǎn)距醫(yī)療應(yīng)用的機(jī)器人需求水漲船高。

市場研究機(jī)構(gòu) ABI Research 的一份最新報告預(yù)測，全球醫(yī)療用機(jī)器人市場規(guī)模將由2011年的不到7.9億美元，在2016年成長至13億美元，主力是高端手術(shù)用機(jī)器人與相關(guān)的自動化放射手術(shù)(radio-surgical )系統(tǒng)。該機(jī)構(gòu)新興科技市場分析師Larry Fisher表示，機(jī)器人技術(shù)多年來已經(jīng)運(yùn)用在某些特定手術(shù)中，隨著病患與醫(yī)師對提升醫(yī)療效果的期望，醫(yī)療用機(jī)器人越來越受歡迎，也加入了其它輔助技術(shù)與遠(yuǎn)距醫(yī)療自動化工具。

雖然采用自動化與輔助技術(shù)有助于讓醫(yī)療過程與相關(guān)活動更簡化、更安全，也更具成本效益，但建置這類技術(shù)的初期成本還是一大門檻，尤其是對較小型的醫(yī)療機(jī)構(gòu)來說；再加上，專為醫(yī)療應(yīng)用所設(shè)計的機(jī)器人系統(tǒng)，需要經(jīng)過復(fù)雜的臨床測試與主觀機(jī)關(guān)審查程序，這也可能使這類產(chǎn)品的定價高昂，上市之路也會十分漫長。

醫(yī)療機(jī)器人市場的采購者本來就限于具備特定資格的醫(yī)療機(jī)構(gòu)或醫(yī)事人員，同時又會受到經(jīng)濟(jì)條件的限制；較小型的醫(yī)療機(jī)構(gòu)恐怕無力負(fù)擔(dān)機(jī)器人的采購預(yù)算，因?yàn)檫@類系統(tǒng)價格動輒數(shù)萬美元，甚至可能高達(dá)400萬美元。因此Fisher表示：“醫(yī)療用機(jī)器人出貨量成長有限，但是由于該類產(chǎn)品的高單價，將使得該市場營收金額在2016年以后達(dá)到數(shù)十億美元水準(zhǔn)。”

Medical robots market to approach USD1.3 billion in 2016, says ABI Research

Julien Happich

RoboTIc technology has been used to provide medical care on a limited basis over the past two decades, helping to make surgical procedures and physical rehabilitaTIon more efficient and effecTIve, and safer for paTIents. Recent advances in robots' technological capabilities, combined with the improving economic environment for medical services delivery and payments, are driving increased demand for surgical, assistive and telemedicine-based robots.

A new study by ABI Research, "Healthcare and Medical Robots" foresees the global market for medical robotics growing from just under USD790 million in 2011 to nearly USD1.3 billion in 2016, driven largely by sales of advanced surgical robots and related automated radio-surgical systems.

Larry Fisher, research director of NextGen (ABI Research's emerging technologies research incubator) says, "While robots to assist surgeons have been used on a limited basis for years, the desire of patients and physicians to maximize the efficiency and effectiveness of medical treatment has led to a recent surge in the popularity of medical robots, as well as to the introduction of additional assistive technologies and telemedicine-based automation tools."

Despite the benefits of using automated and assistive technologies to make medical procedures and activities easier, safer and more cost-effective, the initial cost of implementing such technologies remains a barrier to entry, particularly for smaller medical organizations. Moreover, robotic systems designed for medical care and treatment require significant clinical testing and trials as part of the regulatory approvals process, which can raise these products' price tags, and make their journey to market a lengthy one.

Moreover, the medical robots market is limited by the number of qualified medical institutions or practitioners that can use these devices. This group is further limited by economics; smaller organizations simply may not be able to afford the up-front capital expenditure associated with robots that can cost anywhere from tens of thousands of dollars to more than USD4 million per unit.

As a result, says Fisher, "On a unit basis, the market for medical robots will remain limited. At the same time, however, the high average selling price of most medical robots will help propel revenue to the billion-dollar level and beyond by 2016."